The Cornerstone of Care: Why Hydroxyurea for Sickle Cell is a Primary Treatment
•
4 min read
Sickle cell disease (SCD) affects approximately 100,000 people in the United States [1.9.3]. A key question for many is, 'Why hydroxyurea for sickle cell?' This medication is a primary therapy for reducing the disease's severe complications [1.2.3].
